EBCC-9 | 9th European Breast Cancer | Genomic Segmentation

In this video, developed in association with the European Breast Cancer ConferenceBreast Cancer TV and Quadia Online Video and sponsored by an educational grant from Novartis Oncology:

  • Professor Nadia Harbeck, MD, PhD, head of the Breast Center, Oncological Therapy and Clinical Trials Unit (Hospitals Gro?hadern and Maistrasse-Innenstadt), Dept. OB&GYN, at the Ludwig-Maximilians University of Munich (LMU), Germany, gives a summary with her own conclusions of the EBCC-9 Keynote Symposium on ?How does genomic segmentation address medical needs?,? and
  • She further explains the ADAPT trial and discusses the first results of the run-in phase.

Copyright ? 2014 InPress Media Group/Sunvalley Communication. All rights reserved. Republication or redistribution of InPress Media Group/Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group/Sunvalley Communication. InPress Media Group/Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine and Oncozine are registered trademarks and trademarks of Sunvalley Communication around the world.